US Patent Issued to Dana-Farber Cancer Institute on April 7 for "LMP-1 expressing cells and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,285, issued on April 7, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"LMP-1 expressing cells and methods of use thereof" was invented by Baochun Zhang (Newton, Mass.), Il-Kyu Choi (Boston) and Zhe Wang (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides immunogenic cells expressing LMP1, and use thereof in activating T cells and treating cancer. Also provided are methods of producing the immunogenic cells."

The patent was filed on May 13, 2022, under Application No. 17/663,344.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&...